In the latest trading session, 18.87 million ZyVersa Therapeutics Inc (NASDAQ:ZVSA) shares changed hands as the company’s beta touched 0.53. With the company’s most recent per share price at $0.96 changing hands around $0.38 or 64.97% at last look, the market valuation stands at $2.46M. ZVSA’s current price is a discount, trading about -738.54% off its 52-week high of $8.05. The share price had its 52-week low at $0.55, which suggests the last value was 42.71% up since then. When we look at ZyVersa Therapeutics Inc’s average trading volume, we note the 10-day average is 87310.0 shares, with the 3-month average coming to 853.86K.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA) trade information
Instantly ZVSA is in green as seen in intraday trades today. With action 63.42%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -9.42%, with the 5-day performance at 63.42% in the green. However, in the 30-day time frame, ZyVersa Therapeutics Inc (NASDAQ:ZVSA) is 2.14% up. Looking at the short shares, we see there were 0.19 million shares sold at short interest cover period of 0.44 days.
ZyVersa Therapeutics Inc (ZVSA) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 58.00%.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.24% of ZyVersa Therapeutics Inc shares while 3.16% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 3.16%.
Among Mutual Funds, the top two as of Feb 28, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund. With 4.95 shares estimated at $7128.0 under it, the former controlled 0.19% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.11% of the shares, roughly 2.94 shares worth around $4237.0.